Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02570698 · ClinicalTrials.gov registry record
BM Collection From NICU Infants for Composition
A clinical trial, sponsored by Kimberly-Clark Corporation.
- Completed
- Registry status
- 25
- Enrollment target
NCT02570698 is a clinical trial that has completed, run by Kimberly-Clark Corporation. The registered enrollment target is 25 participants.
The verdict
NCT02570698 has completed, sponsored by Kimberly-Clark Corporation.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The primary objective of this study is to collect feces from premature infants over a five weeks period to characterize its composition. Metabolomics, Proteomics, Genomics and Microbiome analyses and cell-based assays will be performed to identify individual components present in feces, which may contribute to the onset of irritation in the diapered area of premature infants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-01-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02570698
The ClinicalTrials.gov registry entry for NCT02570698 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kimberly-Clark Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02570698 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02570698 about?
NCT02570698 is a clinical study titled "BM Collection From NICU Infants for Composition". The primary objective of this study is to collect feces from premature infants over a five weeks period to characterize its composition. Metabolomics, Proteomics, Genomics and Microbiome analyses and cell-based assays will be performed to identify individual components present in feces, which may co...
What is the current status of trial NCT02570698?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2015-10. Estimated completion is 2017-01-23.
Who is sponsoring clinical trial NCT02570698?
This trial is sponsored by Kimberly-Clark Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.